Provider
QP31-21 Update for New to Market Medical Drugs: Avalglucosidase Alfa and Selexipag (Uptravi intravenous formulation)
Program effective Date: Apr 14, 2021
Documents & Forms Results
Displaying 2131 - 2140 of 3111 results
Provider
QP28-21 Commercial Pharmacy Benefit Exclusion for Select Medications and Formulary Alternatives
Program effective Date: Apr 14, 2021
Provider
P5R2-21 New Reimbursement Policy: Outpatient Services Prior to an Inpatient Admission
Program effective Date: Apr 01, 2021
Provider
P18-21 New Reimbursement Policy for Minnesota Health Care Programs Modifier 90: Reference (Outside) Laboratory and Pass-Through Billing
Program effective Date: Apr 01, 2021
Provider
P11R1-21 UPDATE: Updated Preadmission Services for Inpatient Stays Reimbursement Policy for Minnesota Health Care Programs Members
Program effective Date: Apr 01, 2021
Provider
P19-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Program effective Date: Apr 01, 2021
Provider
P16-21 Genetic/Molecular Lab Test Coding Reimbursement Policy for MHCP
Program effective Date: Apr 01, 2021
Provider
2021 April Bulletins
Program effective Date: Apr 01, 2021
Provider
P17-21 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: Apr 01, 2021
Provider
P15-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates — Effective May 31, 2021
Program effective Date: Apr 01, 2021